Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

CRISPR stocks gain

February 27, 2018 12:56 AM UTC

CRISPR companies added $458 million in market cap on Monday in apparent reaction to two articles published in the past two days.

CRISPR Therapeutics AG (NASDAQ:CRSP) added $5.30 (12%) to $48.34, Intellia Therapeutics Inc. (NASDAQ:NTLA) gained $2.89 (11%) to $29.01 and Editas Medicine Inc. (NASDAQ:EDIT) rose $2.03 to $37.92...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article